The April 15th PR stated that Cytodyne would perfo
Post# of 148288
(Total Views: 797)
Posted On: 07/09/2020 2:25:32 PM
Re: reallypeople? #41836
The April 15th PR stated that Cytodyne would perform an interim analysis on the Phase 2b/3 trial data from 50 patients. Today NP mentioned that (per the FDA,?) the interim analysis would be at 50% enrollment (~190 patients).
So, yeah, I'm not sure when or how that changed or why.
So, yeah, I'm not sure when or how that changed or why.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼